Anavex Life Sciences Corp (AVXL)

[Steady_T]

Children should respond better than adults. At the same time children are vulnerable to developmental issues that adults are not so there is a greater opportunity for negative things to show up in the trial.

I suspect that the recent increase in trial size to allow age grouping analysis of the results is an effort to quantify those possibilities.

If the pediatric trial does not uncover any age related issues then 2-73 is golden.